|
8 October 2003
QED Links DSM and another European Industrial
Giant
A DSM engineer browsing the technology needs posted on QED's
yet2.com marketplace web site triggered the introduction that has
supplied DSM's specialized extrusion technology to another European
industrial giant. DSM is a world-leading producer of life-science
products, performance materials, and industrial chemicals. It is
based in the Netherlands.
“DSM produces a line of mini extruders,” said Ralph
Marx, Licensing Manager for DSM Venturing & Business Development.
“None of our off-the-shelf products were appropriate for the
specific issues raised by the TechNeed that we found posted on yet2.com.
However, because we have substantial experience in this area, we
had expertise in house to supply a custom solution that has proven
to be exactly what the other organization needed.”
“This is a powerful illustration of the results that can
be achieved when a company posts a technology need on yet2.com,”
commented Phil Stern, CEO of QED, which operates the yet2.com Marketplace.
“Although we have access to almost half the world's technology,
not all of it can be posted on the Marketplace as available for
license. A TechNeed can elicit unpublished expertise and technology
that a company might otherwise be unable to find.”
Extrusion in small quantities
The company to whose need DSM responded was looking for a small
scale system to investigate polymer films. Extrusion experiments
usually require kilograms of material. DSM's extrusion expertise
allowed the other company to run their experiments using only tens
of grams of material. The reduction in material requirements by
two orders of magnitude will allow significantly lower risk and
much more rapid prototype development.
Quick turnaround is a hallmark of licensing deals initiated from
technology need postings. A company publicizing its technology need
is in a position to act immediately when contacted by solution providers.
DSM concluded this licensing deal within six months. Traditionally,
licensing deals take as long as 18-24 months.
Thousands of technology needs and licensable technologies are
listed on the yet2.com marketplace by companies large and small.
yet2.com has facilitated thousands of introductions of the type
that lead to the DSM licensing deal.
About DSM
DSM is active worldwide in life science products, performance
materials and industrial chemicals. The group has annual sales (pro
forma including the recently acquired DNP business) of around EUR
8 billion and employs about 25,500 people across the world. DSM
ranks among the global leaders in many of its fields. The company's
strategic aim is to grow its sales – partly through acquisitions
- to a level of approximately EUR 10 billion by 2005.
By that time specialties, i.e. advanced chemical and biotechnological
products for the life science industry and performance materials
should generate at least 80% of sales. This strategy represents
a continuation of the company's ongoing transformation and concentration
on global leadership positions in high-added-value activities characterized
by high growth and more stable profit levels. More information about
DSM can be found at www.dsm.com.
For more information, please contact:
Tim Bernstein, QED Intellectual Property (US)
tbernstein@qed-ip.com
1-617-557-3800
17 Monsignor O’Brien Highway
Cambridge, MA 02141
|
